Inflammation in Atherosclerosis: Current Advances
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 December 2024 | Viewed by 1193
Special Issue Editor
Special Issue Information
Dear Colleagues,
Atherosclerosis is a chronic condition and is the main underlying cause of cardiovascular disease. The development and pathogenesis of atherosclerosis and its clinical consequences (e.g., myocardial infarction and ischemic stroke) are at the crossroads between metabolism and inflammation. Several current treatment therapies target the lowering of low-density lipoprotein cholesterol (LDL) levels. However, there are still a vast number of patients who experience cardiovascular complications. This residual risk is believed to be caused by persistent low-grade inflammation. In recent years, drugs targeting inflammation have been tested in randomized clinical trials with promising results. Pharmacological interventions targeting inflammation may provide new, better treatment outcomes and prevent future cardiac events. Still, there is a lack of knowledge of the molecular mechanisms of inflammation in atherosclerosis and how to target these pathways therapeutically.
This Special Issue will focus on future advancements in the mechanisms and regulation of inflammation in atherosclerosis.
Dr. Tuva B. Dahl
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammation
- atherosclerosis
- cardiovascular disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
